Differential diagnosis
US-10980899-B2 · Apr 20, 2021 · US
US9028802B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9028802-B2 |
| Application number | US-201213683022-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 21, 2012 |
| Priority date | Sep 26, 2007 |
| Publication date | May 12, 2015 |
| Grant date | May 12, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method of differentially diagnosing different types of dementia. In particular, the method relates to the use of specific SPECT tracers for differentially diagnosing Alzheimer's disease, Lewy-Body Dementia, and Frontotemporal Dementia.
Opening claim text (preview).
The invention claimed is: 1. A method of data acquisition for diagnosing and differentiating between different types of dementia, said method comprising: administering at least one compound which is suitable for SPECT, which crosses a blood brain barrier and which is associated with a Dopamine Transporter (DAT) to a human or animal being, said at least one compound selected from the group consisting of Technepine, Fluoratec, TRECTEC-1, TRODAT-1, Altropane®, Dopascan, and DaTSCAN;…
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.